Effects of tetrodotoxin and OKY-046 in renal ischemia reperfusion

Journal of Surgical Research

Volumn 85, Issue 2, 1999, Pages 273-278

  Garvin, Paul J ^a   Niehoff, Michael L ^b   Robinson, Sandra M ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Graft dysfunction; Ischemia eperfusion; Kidney; OKY 046; Rat; Tetrodotoxin; Thromboxane synthetase inhibitor

Indexed keywords

OZAGREL; TETRODOTOXIN; THROMBOXANE A2; THROMBOXANE SYNTHASE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; ORGAN TRANSPLANTATION; PATHOGENESIS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SURVIVAL RATE;

EID: 0032811312     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5685     Document Type: Article

References (27)

1. Transplant. Proc. 18:1986;516.
2. Shackleton C. R., Schechter M. T., Landsberg D. N., Erb S., Seccombe D. W., Scudamore C. H. Effect of perioperative management on initial renal allograft function: An analysis of matched donor pairs. Transplant. Proc. 21:1989;1225.
3. UNOS Sci. Reg. 12:1996;25.
4. Alexander, J. W. Expanded donor criteria: Background and suggestions for kidney donation, UNOS Ad Hoc Donations Committee, 1992.
5. Linas S. L., Whitenberg D., Repine J. E. Role of xanthine oxidase in ischemia reperfusion injury. Am. J. Physiol. 258:1990;F711.
6. McCord J. M. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312:1985;159.
7. Klausner J. M., Paterson I. S., Kobzik L., Rodzen C., Valeri C. R., Shepro D., Hechtman H. B. Vasodilating prostaglandisn attenuate ischemic renal injury only if thromboxane is inhibited. Ann. Surg. 209:1989;219.
8. Cheung J. Y., Bonventre J. V., Malis C. D., Leaf A. Calcium and ischemic injury. N. Engl. J. Med. 314:1986;1670.
9. Spencer A. J., LeFurgey A., Ingram P., Mandel L. J. Elemental microanalysis of organelles in proximal tubules. II. Effects of oxygen deprivation. J. Am. Soc. Nephrol. 1:1991;1321.
10. Matthys F., Patel Y., Kreisberg J., Stewart J. H., Venkatachalam M. Lipid alterations induced by renal ischemia: Pathogenic factor in membrane damage. Kidney Int. 26:1984;153.
11. Kuehl F. A., Egan R. W. Prostaglandins, arachidonic acid, and inflammation. Science. 210:1980;978.
12. Garvin P. J., Niehoff M. L., Robinson S. M., Mistry B., Esterl R., Heisler T., Coombs C. Renoprotective effects of the 21-aminosteroid U74389G in ischemia-reperfusion injury and cold storage preservation. Transplantation. 63:1997;194.
13. Garvin P. J., Niehoff M. L., Robinson S. M., Heisler T., Salinas-Madrigal L., Contis J., Solomon H. Evaluation of the thromboxane A2 synthetase inhibitor OKY-046 in a warm ischemia-repersusion rat model. Transplantation. 61:1996;1429.
14. Narahashi T., Moore J. W., Scott W. R. Tetrodotoxin blockage of sodium conductance increase in lobster giant axons. J. Gen. Physiol. 47:1964;965.
15. + current blockers. Am. J. Physiol. 269:1995;H533.
16. Lelcuk S., Alexander F., Kobzik L., Valeri C. R., Shepro D., Hechtman H. B. Prostacyclin and thromboxane A2 moderate postischemic renal failure. Surgery. 98:1985;207.
17. Guide for the Care and Use of Laboratory Animals. 1985;National Institutes of Health, Bethesda.
18. Li W., Bergman S. M., Holmes R. P., Strandhoy J. W., Handa R. K., McCullough D. L. Tetrodotoxin protects against acute ischemic renal failure in the rat. J. Urol. 147:1992;519.
19. McGiff J. C., Crowshaw K., Terragno N. A., Lonigro A. J. Renal prostaglandins: Possible regulations of the renal action of pressure hormones. Nature. 227:1970;1255.
20. Dunn M. J., Zambroski E. J. Renal effects of drugs that inhibit prostaglandin synthesis. Kidney Int. 18:1980;609.
21. Levenson D. J., Simmons C. E., Brenner B. M. Arachidonic acid metabolism, prostaglandins and the kidney. Am. J. Med. 72:1982;354.
22. Oates J. A., Fitzgerald G. A., Branch R. A., Jackson E. K., Knapp H. R., Roberts I. L. J. Clinical implications of prostaglandin and thromboxane A2 formation. N. Engl. J. Med. 319:1988;761.
23. Kellogg E. W., Fredovick I. Superoxide, hydrogen peroxide and singlet oxygen in lipid peroxidation by a xanthine oxidase system. J. Biol. Chem. 250:1975;8812.
24. Mason J., Beck F., Dorge A., Rick R., Thurau K. Intracellular electrolyte composition following renal ischemia. Kidney Int. 20:1981;61.
25. Carmeliet E. Slow inactivation of the sodium current in rabbit cardiac Purkinge fibres. Pflugers Arch. 408:1987;18.
26. Attwell D., Cohen I., Eisner D., Ohba M., Ojeda C. The steady state TTX-sensitive ("window") sodium current in cardiac Purkinje fibers. Pflugers Arch. 379:1979;137.
27. Coraboeuf E., Deroubaix E., Coulombe A. Effect of tetrodotoxin on action potentials of the conducting system in the dog heart. Am. J. Physiol. 236:1979;H561.